Functional Brands Q2 Loss Widens to $2.6M; Going Concern Doubt Persists
MEHA sits 21% above its 52-week low of $0.004.
Summary
Functional Brands reported a $2.6M Q2 net loss, up from $0.2M a year ago, with going concern doubt reiterated. The BullionFX deal was terminated and the stock now trades on OTC Markets.
Key Events · Earnings and Guidance · MEHA
-
Q2 Net Loss Widens to $2.6M
Net loss increased from $0.2M to $2.6M year-over-year, driven by higher G&A expenses and a $968K non-cash derivative liability charge.
-
Going Concern Doubt Reiterated
Cash of $352K, working capital deficit of $2.9M, and accumulated deficit of $16.7M raise substantial doubt about the company's ability to continue as a going concern.
-
BullionFX Acquisition Terminated
BullionFX terminated the binding letter of intent on June 29, 2026, removing a potential strategic alternative for the company.
-
Nasdaq Delisting Completed
The company's common stock was delisted from Nasdaq and now trades on OTC Markets under ticker MEHA, limiting access to capital markets.
Analysis · MEHA · Life Sciences
The second quarter results reveal a sharp deterioration in profitability, with net loss expanding from $0.2M to $2.6M year-over-year. Revenue grew modestly and gross margin improved, but operating expenses more than doubled, driven by public-company costs and professional fees. The balance sheet remains under severe stress: cash of only $352K, a working capital deficit of $2.9M, and an accumulated deficit of $16.7M. Management explicitly reiterates substantial doubt about the company's ability to continue as a going concern. The termination of the BullionFX acquisition removes a potential strategic lifeline, and the Nasdaq delisting further limits capital-raising options. This filing confirms the company is in a precarious financial position with no clear path to stability.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 35.7% of the 1024 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MEHA was trading at $0.00 on OTC in the Life Sciences sector, with a market capitalization of approximately $204.6K. The 52-week trading range was $0.00 to $8.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.